{"id":"W2169431633","doi":"10.1016/s0140-6736(09)62038-9","title":"Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial","year":2010,"lang":"en","type":"article","venue":"The Lancet","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Allergy and Infectious Diseases; National Institute of Mental Health; National Heart, Lung, and Blood Institute; U.S. Public Health Service","keywords":"Medicine; Placebo; Clinical endpoint; Hazard ratio; Internal medicine; Viral load; Herpes simplex virus; Aciclovir; Gastroenterology; Randomized controlled trial; Immunology; Confidence interval; Virus; Viral disease; Herpesviridae; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002000506,0.002930076,0.007484313,0.001074151,0.001007936,0.001931523,0.001665215,0.004455785,0.01537246],"category_scores_gemma":[0.003033131,0.001617396,0.003480858,0.0009066759,0.002646328,0.002230598,0.0008544213,0.005048311,0.001682776],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001270771,"about_ca_system_score_gemma":0.001218534,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002412943,"about_ca_topic_score_gemma":0.003687042,"domain_scores_codex":[0.9986632,0.000598414,0.0001041964,0.0002794677,0.00009109629,0.0002636851],"domain_scores_gemma":[0.9984657,0.0005027634,0.0002517624,0.0001186877,0.0001078425,0.0005533512],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9910143,0.001902585,0.0001177399,0.0007222258,0.0005416033,0.00002435961,0.00002977028,0.00006323393,0.000550754,0.00005288363,0.0002496782,0.004730902],"study_design_scores_gemma":[0.9812135,0.01770387,0.0003549797,0.00003646329,0.0002932699,0.00001013432,0.00001397087,0.00006163261,0.00005013029,0.00005838421,0.0001960462,0.000007635916],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9550426,0.0238863,0.001283129,0.001599008,0.003773818,0.007718895,0.001922932,0.0003036688,0.004469778],"genre_scores_gemma":[0.9761423,0.00880209,0.001407675,0.001298726,0.001498724,0.004834412,0.0007903834,0.0000310493,0.005194684],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01537246,"threshold_uncertainty_score":0.05142599,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.015807759422604,"score_gpt":0.3041585563822332,"score_spread":0.2883507969596292,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}